FasL-over-expressing T lymphocytes as effector cells in anti-prostate cancer gene therapy

被引：0
|
作者：
Bielawski, JC
Fowler, DH
Medin, JA
机构：
[1] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada
[2] NCI, Expt Transplantat & Immunol Branch, NIH, Bethesda, MD 20892 USA
[3] Ontario Canc Inst, Div Expt Therapeut, Toronto, ON M4X 1K9, Canada
来源：
MOLECULAR THERAPY | 2004年 / 9卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
950
引用
收藏
页码：S364 / S364
页数：1
相关论文
共 50 条
  • [41] Colorectal cancer microenvironment expressing BTN3A1 stimulate effector γδ T cells with anti-tumor activity upon zoledronate treatment
    Zocchi, M. R.
    Costa, D.
    Vene, R.
    Tosetti, F.
    Ferrari, N.
    Minghelli, S.
    Benelli, R.
    Scabini, S.
    Romairone, E.
    Catellani, S.
    Profumo, A.
    Poggi, A.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 : 140 - 140
  • [42] Humoral and Cellular Immunology in Human Prostate Cancer: Plasma Cells and T and B Lymphocytes
    Hector, Rodriguez
    Nicolas, Rodriguez
    Ivan, Gallegos
    Camilo, Arriaza
    Espinoza-Navarro, Omar
    INTERNATIONAL JOURNAL OF MORPHOLOGY, 2023, 41 (05): : 1558 - 1563
  • [43] Dendritic cell transduced survivin gene induce specific cytotoxic T lymphocytes in prostate cancer
    Kikkawa, Kazuro
    Fujii, Reona
    Kuramoto, Tomorni
    Mori, Takashi
    Inagaki, Takeshi
    Kohjimoto, Yasuo
    Iwahashi, Makoto
    Uekado, Yasunari
    Yamaue, Hiroki
    Shinka, Toshiaki
    JOURNAL OF UROLOGY, 2007, 177 (04): : 181 - 182
  • [44] Gene-Modified Human α/β-T Cells Expressing a Chimeric CD16-CD3ζ Receptor as Adoptively Transferable Effector Cells for Anticancer Monoclonal Antibody Therapy
    Ochi, Fumihiro
    Fujiwara, Hiroshi
    Tanimoto, Kazushi
    Asai, Hiroaki
    Miyazaki, Yukihiro
    Okamoto, Sachiko
    Mineno, Junichi
    Kuzushima, Kiyotaka
    Shiku, Hiroshi
    Barrett, John
    Ishii, Eiichi
    Yasukawa, Masaki
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (03) : 249 - 262
  • [45] Anti-prostate cancer protection and therapy in the framework of predictive, preventive and personalised medicine - comprehensive effects of phytochemicals in primary, secondary and tertiary care
    Mazurakova, Alena
    Samec, Marek
    Koklesova, Lenka
    Biringer, Kamil
    Kudela, Erik
    Al-Ishaq, Raghad Khalid
    Pec, Martin
    Giordano, Frank A.
    Busselberg, Dietrich
    Kubatka, Peter
    Golubnitschaja, Olga
    EPMA JOURNAL, 2022, 13 (03): : 461 - 486
  • [46] Generation of Potent Cytotoxic T Lymphocytes Against Castration-Resistant Prostate Cancer Cells by Dendritic Cells Loaded With Dying Allogeneic Prostate Cancer Cells
    Hwang, E. C.
    Lim, M. -S.
    Im, C. -M.
    Kwon, D. -D.
    Lee, H. -J.
    Nguyen-Pham, T. -N.
    Lee, Y. -K.
    Lee, J. -J.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2013, 77 (02) : 117 - 124
  • [47] Anti-prostate cancer protection and therapy in the framework of predictive, preventive and personalised medicine — comprehensive effects of phytochemicals in primary, secondary and tertiary care
    Alena Mazurakova
    Marek Samec
    Lenka Koklesova
    Kamil Biringer
    Erik Kudela
    Raghad Khalid Al-Ishaq
    Martin Pec
    Frank A. Giordano
    Dietrich Büsselberg
    Peter Kubatka
    Olga Golubnitschaja
    EPMA Journal, 2022, 13 : 461 - 486
  • [48] Hypoxia regulates the differentiation and anti-tumor effector functions of γδT cells in oral cancer
    Sureshbabu, S. K.
    Chaukar, D.
    Chiplunkar, S. V.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2020, 201 (01): : 40 - 57
  • [49] Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancer
    Lamers, CHJ
    Willemsen, RA
    Luider, BA
    Debets, R
    Bolhuis, RLH
    CANCER GENE THERAPY, 2002, 9 (07) : 613 - 623
  • [50] Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancer
    Cor H J Lamers
    Ralph A Willemsen
    Barbara A Luider
    Reno Debets
    Reinder L H Bolhuis
    Cancer Gene Therapy, 2002, 9 : 613 - 623
12345